BlackBerry Outlines Framework to Secure Connected and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
32
BlackBerry Outlines Framework to Secure Connected and Autonomous Vehicles

WATERLOO, ONTARIO--(Marketwired - Dec. 6, 2017) - While the integration of technology and connectivity in automobiles greatly improves the driving experience, it also creates complex cybersecurity challenges for automakers. To address these new concerns, BlackBerry Limited (NYSE:BB)(TSX:BB) today laid out a recommended framework to harden connected and autonomous vehicles against cyberattacks.

"Protecting a car from cybersecurity threats requires a holistic approach," said Sandeep Chennakeshu, President of BlackBerry Technology Solutions. "Leveraging our experience as a leader in cybersecurity and embedded automotive software, BlackBerry has created a recommended framework to protect cars from cybersecurity threats. If followed, we believe vehicles will not only be secure but BlackBerry Secure."

Within this framework, automakers and their supply chains can deploy their technology choices to differentiate.
BlackBerry's recommendation leverages the company's proven expertise in security and accounts for industry trends in connectivity and automated driving. The key points, outlined in the whitepaper titled "Cybersecurity for Automobiles: BlackBerry's 7-Pillar Recommendation," are summarized below. The full version of the whitepaper can be downloaded here.

  1. Secure the supply chain: Establish a root of trust by ensuring every chip and electronic control unit (ECU) in the automobile can be properly authenticated and loaded with trusted software, irrespective of vendor or manufacturer. Scan all software deployed for compliance to standards and required security posture. Conduct regular evaluations of the supply chain from a vulnerability and penetration testing perspective to ensure they are certified and "approved for delivery."

  1. Use trusted components: Create a security architecture that is deeply layered in a defense in depth architecture, with secure hardware, software, and applications.

  1. Employ isolation and trusted messaging: Use an electronic system architecture that isolates safety critical and non-safety critical ECUs and can also "run-safe" when anomalies are detected. Additionally, ensure all communication between the electronics in the automobile and the external world are trusted and secure. Further, ECU-to-ECU communication needs to be trusted and secure.

  1. Conduct in-field health checks: Ensure all ECUs have integrated analytics and diagnostics software that can capture events, and are able to log and report the same to a cloud-based tool for further analysis and to initiate preventative actions. Moreover, automakers should confirm that a defined set of metrics can be scanned regularly when the car is in the field, as well as be able to take actions to address issues via secure over-the-air (OTA) software updates.

  1. Create a rapid incident response network: Share common vulnerabilities and exposures among a network of subscribing enterprises so expert teams can learn from each other and provide advisories and fixes in shorter time frames.

  1. Use a lifecycle management system: Proactively re-flash a vehicle with secure OTA software updates as soon as an issue is detected. Manage security credentials via active certificate management. Deploy unified endpoint policy management to manage applications downloaded over the lifetime of the car.

  1. Make safety and security a part of the culture: Ensure every organization involved in supplying auto electronics is trained in functional safety and security best practices to inculcate this culture within the organization.

BlackBerry has developed and is developing innovative technologies, tools, and services for each of these 7-Pillars. The company will demonstrate its vision for connected cars and autonomous vehicles at the 2018 Consumer Electronics Show in Las Vegas on January 9-12 (Booth #7523, North Hall). For reporters interested in meeting with BlackBerry, please email mediarelations@blackberry.com.

About BlackBerry

BlackBerry is a cybersecurity software and services company dedicated to securing the Enterprise of Things. Based in Waterloo, Ontario, the company was founded in 1984 and operates in North America, Europe, Asia, Australia, Middle East, Latin America and Africa. The Company trades under the ticker symbol "BB" on the Toronto Stock Exchange and New York Stock Exchange. For more information, visit www.BlackBerry.com.

BlackBerry and related trademarks, names and logos are the property of BlackBerry Limited and are registered and/or used in the U.S. and countries around the world. All other marks are the property of their respective owners. BlackBerry is not responsible for any third-party products or services.

BlackBerry Media Relations:
(519) 597-7273
mediarelations@blackberry.com

BlackBerry Investor Relations:
(519) 888-7465
investorinfo@blackberry.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading